Search research articles
Contact Us
Filters
Showing results (681-690 of 697) with videos related to
Page
of 70
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2025
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD
Xiao-Dong Zhou, Qin-Fen Chen, Seung Up Kim, et al.
Gastroenterology
|
March 20, 2025
From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic Perspective
Wen-Yue Liu, Shanshan Huang, Hongsheng Ji, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 8, 2026
Progression of Liver Fibrosis and Liver-Related Event Risk in MASLD at High Cardiovascular Risk
Xiao-Dong Zhou, Qin-Fen Chen, Seung Up Kim, et al.
Gut
|
June 20, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
Jimmy Che-To Lai, Boyu Yang, Hye Won Lee, et al.
Gut
|
August 1, 2024
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
Xiao-Dong Zhou, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 1, 2026
ONE-YEAR CHANGES IN LSM, BUT NOT IN ALT AND CAP, PREDICT LONG-TERM LIVER OUTCOMES IN PATIENTS WITH MASLD
Grazia Pennisi, Giuseppe Infantino, Gabriele Di Maria, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 11, 2025
A Novel Risk Prediction Model for Hepatocellular Carcinoma in MASLD: A Multinational, Multicenter Cohort Study
Ho Soo Chun, Minjong Lee, Hye Ah Lee, et al.
Hepatology (Baltimore, Md.)
|
December 16, 2025
Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
Xiao-Dong Zhou, Qin-Fen Chen, Qiong-Yue Fan, et al.
European Urology
|
May 1, 2024
Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial
Jeremy Yuen-Chun Teoh, Cheung-Hing Cheng, Chiu-Fung Tsang, et al.
European Urology Oncology
|
November 2, 2025
Impact of Intravesical Bacillus Calmette-Guérin Therapy Following Transurethral En Bloc Resection of Bladder Tumour: Post Hoc Analysis of a Randomised, Multicentre, Phase 3 Trial
Jeremy Yuen-Chun Teoh, Chris Ho-Ming Wong, Cheung-Hing Cheng, et al.
Page
of 70
Search research articles
Search
Showing results (681-690 of 697) with videos related to
Sort By:
Page
of 70
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 11, 2025
Long-Term Glycemic Control and the Risk of Liver Stiffness Progression and Liver-Related Events in MASLD
Xiao-Dong Zhou, Qin-Fen Chen, Seung Up Kim, et al.
Gastroenterology
|
March 20, 2025
From "Burnt-Out" to "Burning-Out": Capturing Liver Fat Loss in Patients With Advanced Metabolic Dysfunction-Associated Steatotic Liver Disease From a Dynamic Perspective
Wen-Yue Liu, Shanshan Huang, Hongsheng Ji, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 8, 2026
Progression of Liver Fibrosis and Liver-Related Event Risk in MASLD at High Cardiovascular Risk
Xiao-Dong Zhou, Qin-Fen Chen, Seung Up Kim, et al.
Gut
|
June 20, 2025
Non-invasive risk-based surveillance of hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease
Jimmy Che-To Lai, Boyu Yang, Hye Won Lee, et al.
Gut
|
August 1, 2024
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
Xiao-Dong Zhou, Seung Up Kim, Terry Cheuk-Fung Yip, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
February 1, 2026
ONE-YEAR CHANGES IN LSM, BUT NOT IN ALT AND CAP, PREDICT LONG-TERM LIVER OUTCOMES IN PATIENTS WITH MASLD
Grazia Pennisi, Giuseppe Infantino, Gabriele Di Maria, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 11, 2025
A Novel Risk Prediction Model for Hepatocellular Carcinoma in MASLD: A Multinational, Multicenter Cohort Study
Ho Soo Chun, Minjong Lee, Hye Ah Lee, et al.
Hepatology (Baltimore, Md.)
|
December 16, 2025
Cardiovascular-Kidney-Metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD
Xiao-Dong Zhou, Qin-Fen Chen, Qiong-Yue Fan, et al.
European Urology
|
May 1, 2024
Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial
Jeremy Yuen-Chun Teoh, Cheung-Hing Cheng, Chiu-Fung Tsang, et al.
European Urology Oncology
|
November 2, 2025
Impact of Intravesical Bacillus Calmette-Guérin Therapy Following Transurethral En Bloc Resection of Bladder Tumour: Post Hoc Analysis of a Randomised, Multicentre, Phase 3 Trial
Jeremy Yuen-Chun Teoh, Chris Ho-Ming Wong, Cheung-Hing Cheng, et al.
Page
of 70